Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial HypertensionYann Grobs, Sébastien Bonnet, Valérie Nadeau et al.|International Journal of Molecular Sciences|2021Cited by 16
Abstract 10742: Implication of the Importins KPNA2 and KPNB1 in Pulmonary Arterial HypertensionSarah‐Eve Lemay, François Potus, Charifa Awada et al.|Circulation|2021Cited by 1
Abstract 16770: The Epigenetic Modifier EP300: A New Corner Stone in the Regulation of Both Vascular Remodeling and Right Ventricle Failure in Pulmonary Arterial HypertensionAlice Bourgeois, Sébastien Bonnet, Olivier Boucherat et al.|Circulation|2020Cited by 0